Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a ...

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those without MDD.

Up to 12 months, psychological interventions showed preventive effects for major depressive disorder reducing symptom severity and incidence.

Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.

Navacaprant is an highly selective kappa opioid receptor antagonist expected to modulate reward processing pathways and mediate depressive states.

A study of older adults showed that 6% had depression, with higher prevalences in certain groups, including women, those who ...

Older adults with major depression exhibit unique patterns of risky driving independent of antidepressant use, suggesting the need for targeted interventions to ensure safety.

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those without MDD, according to a study published online Dec. 30 in JAMA Network Open.

In this longitudinal cohort study of older drivers, adults with major depressive disorder demonstrated distinct and riskier driving behaviors than those in the control group without depression, with ...

Unlike major depressive disorder, seasonal affective disorder usually lasts anywhere from a couple of weeks to a few months.

—Major depressive disorder and treatment-resistant depression both require high levels of resources—both clinical and economic—across the spectrum of healthcare settings. A new study from ...